Penile Constriction Devices as Non-Pharmacological Adjuncts to Phosphodiesterase-5 Inhibitors in Refractory Erectile Dysfunction: A Mechanistic and Clinical Review
Background: Oral phosphodiesterase type 5 (PDE5) inhibitors are established first-line pharmacotherapies for erectile dysfunction (ED), yet approximately 30% to 35% of patients fail to achieve satisfactory rigidity. Objective: To review the physiological rationale, clinical efficacy evidence, and safety profile of external penile constriction devices (PCDs)—applied alone or banded with vacuum erection therapy—as mechanical adjuncts to salvage PDE5 inhibitor non-responders, and to propose a structured clinical escalation protocol. Results: Combination therapy leverages complementary physiological mechanisms: PDE5 inhibitors amplify NO-mediated cavernosal smooth muscle relaxation, whereas external constriction rings restrict venous drainage through Buck's fascia. Conclusions: External penile constriction devices represent an underutilized, non-invasive, low-cost salvage modality prior to initiating invasive therapies. Conflict of Interest: Dr. Mohd Amiruddin Mohd Nor is the clinical founder and medical director of SuamiSihat Clinic and has commercial involvement with the Dr MIT Ring constriction device.
Authors
- Mohd Amiruddin Mohd Nor
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24298542
- Primary Topic
- Sexual function and dysfunction studies
- Type
- preprint